Inflammatory gene signatures are at present being explored as predictive biomarkers for immune checkpoint blockade (ICB), and significantly for the remedy of renal cell cancers.
Expression Pathology Inc. (EPI) Biotechnology
Multiplex tissue proteomic assays using FFPE IHC analysis